Researchers have developed a model to predict overall survival for people with advanced urothelial cancers treated with the immune checkpoint inhibitor atezolizumab. The model, which is based on six clinical factors, may help inform treatment decisions...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nHGOtu
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
The long-terminal repeat retrotransposon Ty1 is the most abundant mobile genetic element in many Saccharomyces cerevisiae isolates. Ty1 retr...
-
FOX Carolina Eight updates in oral head and neck cancer Healio Oral Head and Neck Cancer Awareness Week — led by the Head and Neck ...
-
Abstract AFLP analysis of 144 samples of tetraploid wheat species, including cultivars and landraces of Triticum durum from Azerbaijan, w...
-
Plains Indian War shields | Buffalo hump shields | Dance Shields | Medicine Shields from #AlexandrosSfakianakis via Alexandros G.Sfakianak...
-
Prof Stupp speaks with ecancer at AACR 2017 about developing treatments for glioblastoma, from temozolomide and chemotherapy to novel tumour...
-
Bacteria increasingly resistant to antibiotics are a major treatment concern of respiratory tract pathogens in children. The aim of this stu...
-
Abstract Objective A large proportion of paediatric patients with attention-deficit/hyperactivity disorder (ADHD) have associated sleep ...
-
Wendy Y. Carter, . Looking for Thesis Proposal Writing Software? If you are looking for software to help you write your thesis proposal, che...
-
Blaschke S, O'Callaghan CC, Schofield P. Identifying opportunities for nature engagement in cancer care practice and design: protocol fo...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2noRorl via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου